【摘要】 目的 探讨应用尼莫通微创治疗脑出血、继发性脑室出血临床疗效及对并发脑血管痉挛、脑梗死后遗症及死亡率的影响。方法 对29例脑出血、继发性脑室出血应用尼莫通微创治疗，另有对照组21例单纯应用脱水降颅压、止血剂、控制血压和防止感染等，比较两组临床疗效、后遗症及死亡率。结果 治疗组总有效率89.7%，对照组52.4%(P<0.05)，应用尼莫通微创治疗可明显减少后遗症和死亡率的发生。结论 应用尼莫通微创治疗脑出血、继发性脑室出血，疗效显著，且明显减少后遗症和死亡率。

    【关键词】 尼莫通； 微创； 脑出血； 继发性脑室出血

    The observation of minitrauma and Nimotop in the treatment of cerebral hemorrhage or secondary ventricuiar hemorrhage.

    ZHAO Chuan-kui，LIU Gang-tie,YE Wei-wei.

    Department of Internal Medicine. The People’s Hospital of Yingshang.Anhui 236200, China

    【Abstract】 Objective To strdy the clinical efficacy of minitrauma and Nimotop in the treatment of cerebral hemorrhage or secondary ventricular hemorrhage. Methods 44 patients with cerebral hemorrhage or secondary ventricular hemorrhage were divided randomly into two groups. 19 patients (Group A) snd 25 patients (Group B) were treated with dehydrant/ hemostat and minitraume / Nimotop respectively .The overall response rate (care rate,effective rate), the incidence of sequela (cerebral infarction and supranuclear paralysis) and the death rate were analyzed between two griups. Results Compared with Group A, the use of minitrauma and Nimotop resulted in higher response rates (89.7% Versus 52.4%. P<0.05) and decreased the incidence of sequela and the death rate significantly. Hypotension was more frequent in Group B. Conclusion Minitrauma and Nimotop is effective and safe in the treatment of cerebral hemorrhage or secondary ventricuiar hemorrhage. ......